Seastar Medical Holding Stock Market Value
| ICU Stock | USD 2.58 0.01 0.39% |
| Symbol | SeaStar |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SeaStar Medical. If investors know SeaStar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SeaStar Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.30) | Revenue Per Share | Quarterly Revenue Growth 1.691 | Return On Assets | Return On Equity |
The market value of SeaStar Medical Holding is measured differently than its book value, which is the value of SeaStar that is recorded on the company's balance sheet. Investors also form their own opinion of SeaStar Medical's value that differs from its market value or its book value, called intrinsic value, which is SeaStar Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SeaStar Medical's market value can be influenced by many factors that don't directly affect SeaStar Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SeaStar Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if SeaStar Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SeaStar Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
SeaStar Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SeaStar Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SeaStar Medical.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in SeaStar Medical on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding SeaStar Medical Holding or generate 0.0% return on investment in SeaStar Medical over 90 days. SeaStar Medical is related to or competes with Apollomics, Moleculin Biotech, Citius Pharmaceuticals, Lunai Bioworks, Aditxt, Ainos, and Tharimmune. SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to trea... More
SeaStar Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SeaStar Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SeaStar Medical Holding upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 34.66 | |||
| Value At Risk | (9.88) | |||
| Potential Upside | 9.58 |
SeaStar Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SeaStar Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SeaStar Medical's standard deviation. In reality, there are many statistical measures that can use SeaStar Medical historical prices to predict the future SeaStar Medical's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.25) | |||
| Total Risk Alpha | (1.76) | |||
| Treynor Ratio | (0.57) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of SeaStar Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
SeaStar Medical January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.56) | |||
| Mean Deviation | 4.81 | |||
| Coefficient Of Variation | (628.15) | |||
| Standard Deviation | 6.93 | |||
| Variance | 48.02 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (1.25) | |||
| Total Risk Alpha | (1.76) | |||
| Treynor Ratio | (0.57) | |||
| Maximum Drawdown | 34.66 | |||
| Value At Risk | (9.88) | |||
| Potential Upside | 9.58 | |||
| Skewness | 0.3712 | |||
| Kurtosis | 3.06 |
SeaStar Medical Holding Backtested Returns
SeaStar Medical Holding owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.15, which indicates the firm had a -0.15 % return per unit of risk over the last 3 months. SeaStar Medical Holding exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate SeaStar Medical's Risk Adjusted Performance of (0.11), variance of 48.02, and Coefficient Of Variation of (628.15) to confirm the risk estimate we provide. The entity has a beta of 1.94, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, SeaStar Medical will likely underperform. At this point, SeaStar Medical Holding has a negative expected return of -1.04%. Please make sure to validate SeaStar Medical's skewness, and the relationship between the total risk alpha and day median price , to decide if SeaStar Medical Holding performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.47 |
Average predictability
SeaStar Medical Holding has average predictability. Overlapping area represents the amount of predictability between SeaStar Medical time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SeaStar Medical Holding price movement. The serial correlation of 0.47 indicates that about 47.0% of current SeaStar Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for SeaStar Stock Analysis
When running SeaStar Medical's price analysis, check to measure SeaStar Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SeaStar Medical is operating at the current time. Most of SeaStar Medical's value examination focuses on studying past and present price action to predict the probability of SeaStar Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SeaStar Medical's price. Additionally, you may evaluate how the addition of SeaStar Medical to your portfolios can decrease your overall portfolio volatility.